AGE20s ESSENCE COVER PACT ORIGINAL WHITE LATTE 23
- Manufacturer
- Aekyung Industrial Co., Ltd.
- Effective date
- 2020-06-23
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:24:44
Label at a glance#
ProductAGE20s ESSENCE COVER PACT ORIGINAL WHITE LATTE 23
Active ingredientTITANIUM DIOXIDE, OCTINOXATE, OCTOCRYLENE
Label structure1 sections
Label contents#
Full prescribing information#
Products#
Every source-derived product name is available through these pages.
- AGE20s ESSENCE COVER PACT ORIGINAL WHITE LATTE 23
- Titanium Dioxide, Ethylhexyl Methoxycinnamate, Octocrylene
- HYALURONIC ACID
- FERRIC OXIDE RED
- FERRIC OXIDE YELLOW
- FERROSOFERRIC OXIDE
- ALUMINUM OXIDE
- ALUMINUM HYDROXIDE
- MICA
- C30-45 OLEFIN
- C30-45 ALKYL METHICONE
- HYALURONATE SODIUM
- CYCLOMETHICONE 5
- CYCLOMETHICONE 6
- NIACINAMIDE
- CANDELILLA WAX
- HYDROGENATED POLYBUTENE (1300 MW)
- SILICON DIOXIDE
- PHENYL TRIMETHICONE
- MONOSODIUM GLUTAMATE
- CETYL PEG/PPG-10/1 DIMETHICONE (HLB 2)
- VINYLPYRROLIDONE/HEXADECENE COPOLYMER
- P-ANISIC ACID
- TRIETHOXYCAPRYLYLSILANE
- GLYCERYL CAPRYLATE
- STEARIC ACID
- DIMETHICONE
- BUTYLENE GLYCOL
- DIPROPYLENE GLYCOL
- CETEARYL NONANOATE
- ADENOSINE
- LAVANDULA ANGUSTIFOLIA WHOLE
- ORIGANUM VULGARE SUBSP. HIRTUM WHOLE
- POLYMETHYLSILSESQUIOXANE (4.5 MICRONS)
- ROSMARINUS OFFICINALIS WHOLE
- THYMUS VULGARIS WHOLE
- WATER
- LEMON
- CASEIN
- PEARL (HYRIOPSIS CUMINGII)
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 67225-1123 | 67225-1123-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| dec82443-c27e-f428-e053-2995a90ac8ac | a1faa59e-f025-f4bf-e053-2995a90a617a | 2022-05-11 | a1faa59e-f025-f4bf-e053-2995a90a617a |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
